Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Cult of Lululemon Athletica Inc. (LULU)

Page 1 of 2
Investors continue to pay a high premium for Lululemon Athletica Inc. (NASDAQ:LULU)‘s cult-like following and strong growth and expansion prospects.  There is a voracious appetite among a vocal group of the company’s fanatics for all things Lulu.  Searches for “yoga pants” and “Lululemon” are at all-time highs on Google Trends, signaling peak interest.  The company continues to grow organic sales at 20+% rates while adding new stores, making the Canada-based enterprise one of the hottest brands of the past several years.  But can this trend continue and will the brand continue to grow in 2013 and beyond? Creating such a strong appetite for Lululemon’s apparel begins with grass-roots marketing a specific targeted consumer base: women with money.  Lulu’s brand “ambassadors,” typically local female yoga instructors, actively market to these women, specifically in yoga classes.  Customer interaction with the brand has been highly successful because it is so much more engaging than just watching a commercial or reading a Tweet.
Lululemon Athletica inc. (NASDAQ:LULU)
By creating a huge market for yoga gear, Lulu has invited a host of new competition into this segment of the apparel arena. Nordstrom, Inc. (NYSE:JWN)‘s in-house brand Zella has the same look and feel as the Lululemon line.  With such a wide geographic footprint and cross-selling ability, Nordstrom can afford to discount so the price of similar yoga gear is about half of Lululemon’s.  As competition for the yoga pant market heats up, expect to see several more knockoff and discount replicas enter the marketplace.

From an enterprise value standpoint, Lululemon is worth double that of apparel rival Under Armour Inc (NYSE:UA).  While they do not possess astronomical brand value, or as high growth expectations as Lululemon, Under Armour does have higher sales in dollar terms and a much wider customer base.

While Lululemon’s consumers are mainly women (specifically professional, young and athletic), Under Armour has a deeper market that encompasses both sexes and multiple income levels.  This diversity in customer base allows Under Armour more room for error in case of a branding misstep, such as a poor product launch or entry into an unsuccessful market.  When held to standard of operational perfection, as Lululemon’s shares are priced, Under Armour looks cheap and the more reasonable pick of the two for an investor versus a trader.

“Our success depends on our ability to maintain the value and reputation of our brand.”

This is the first risk factor quoted from Lululemon’s latest 10-Q, and it tells the whole story for the company’s future prospects.  Hot brands are hot until they’re not.  Just ask John McCarvel, CEO of Crocs, Inc. (NASDAQ:CROX), about the importance of keeping a brand relevant.  From 2006-2008, sales at the shoe company exploded, as the endearing plastic footwear appeared on beach-goers and weekend warriers all over the world.  Crocs stock price followed higher, and peaked at an enterprise value over $4 billion in October 2008.

But the Great Recession forced consumers to trim expenditures and competition increased.  Knockoff Crocs were available in every Dollar General and Wal-Mart in sight, and consumers were not willing to continue paying for the brand.  The company was forced to discount in order to move inventory and brand perception was permanently damaged.  While still relevant in certain niches, Crocs is not what it was during their glory days.  The company’s value has shrunk to $1 billion today.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!